IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE

IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE was reported 4092 times

IMMUNE GLOBULIN INFUSION (HUMAN), 10% WITH RECOMBINANT HUMAN HYALURONIDASE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CAMPYLOBACTER BACTERAEMIA 4 0.1333
1 ALLERGY TO IMMUNOGLOBULIN THERAPY 9 0.0826
2 PAEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME 3 0.0638
3 INFUSION SITE DISCOMFORT 60 0.0579
4 ADMINISTRATION SITE CELLULITIS 2 0.0571
5 RETROPERITONEAL CANCER 4 0.0500
6 DERMAL ABSORPTION IMPAIRED 12 0.0429
7 PRIMARY IMMUNODEFICIENCY SYNDROME 3 0.0370
8 INFUSION SITE SWELLING 215 0.0341
9 MALABSORPTION FROM INJECTION SITE 10 0.0323
10 INFUSION SITE PAPULE 3 0.0316
11 INFUSION SITE PRURITUS 99 0.0313
12 SENSORY PROCESSING DISORDER 5 0.0296
13 RETROPERITONEAL MASS 4 0.0290
14 INFUSION SITE DISCHARGE 50 0.0285
15 INFUSION SITE WARMTH 34 0.0277
16 GRAVITATIONAL OEDEMA 18 0.0259
17 INFUSION SITE ERYTHEMA 218 0.0258
18 INFUSION SITE HYPERSENSITIVITY 3 0.0250
19 INFUSION SITE DISCOLOURATION 20 0.0227
20 DEVICE INFUSION ISSUE 54 0.0218
21 INFUSION SITE ULCER 2 0.0217
22 MALABSORPTION FROM ADMINISTRATION SITE 5 0.0216
23 INFUSION SITE NECROSIS 4 0.0208
24 INFUSION SITE BRUISING 45 0.0208
25 INFUSION SITE SCAR 9 0.0203
26 INFUSION SITE EXTRAVASATION 124 0.0199
27 LARYNGITIS VIRAL 2 0.0189
28 INFUSION SITE MASS 20 0.0184
29 ANTI-GAD ANTIBODY POSITIVE 2 0.0179
30 GENITAL SWELLING 12 0.0174
31 INFUSION SITE PAIN 223 0.0173
32 INFUSION SITE URTICARIA 11 0.0164
33 ITCHING SCAR 2 0.0155
34 ADMINISTRATION SITE PRURITUS 2 0.0155
35 BLOOD IMMUNOGLOBULIN G DECREASED 38 0.0153
36 INFUSION SITE RASH 21 0.0153
37 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 8 0.0143
38 INFUSION SITE INDURATION 21 0.0142
39 BLOOD IMMUNOGLOBULIN A DECREASED 9 0.0138
40 INFUSION SITE HAEMORRHAGE 44 0.0134
41 MENINGITIS ASEPTIC 60 0.0134
42 INFUSION SITE VESICLES 7 0.0133
43 MEDICAL DEVICE SITE DISCHARGE 2 0.0131
44 IMMUNOGLOBULINS DECREASED 17 0.0124
45 BLOOD IMMUNOGLOBULIN G ABNORMAL 2 0.0120
46 INFUSION SITE ABSCESS 6 0.0119
47 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 17 0.0118
48 INFUSION SITE IRRITATION 15 0.0117
49 IMMUNOGLOBULINS ABNORMAL 3 0.0115
50 INFUSION SITE INJURY 2 0.0114
51 INFUSION SITE REACTION 32 0.0107
52 ADMINISTRATION SITE DISCOMFORT 2 0.0106
53 INFUSION SITE NODULE 10 0.0104
54 NAIL HYPERTROPHY 2 0.0099
55 METABOLIC DYSFUNCTION-ASSOCIATED LIVER DISEASE 2 0.0097
56 INCORRECT DRUG ADMINISTRATION RATE 41 0.0096
57 LOCAL REACTION 7 0.0094
58 ADMINISTRATION SITE SWELLING 3 0.0092
59 MONOCLONAL IMMUNOGLOBULIN PRESENT 7 0.0092
60 NONREASSURING FOETAL HEART RATE PATTERN 2 0.0090
61 GRIP STRENGTH 2 0.0087
62 INFUSION SITE OEDEMA 7 0.0084
63 RETROPERITONEAL LYMPHADENOPATHY 4 0.0076
64 MORAXELLA INFECTION 2 0.0073
65 ADMINISTRATION SITE ERYTHEMA 2 0.0070
66 MICTURITION FREQUENCY DECREASED 5 0.0067
67 BREAST INFLAMMATION 2 0.0065
68 EHLERS-DANLOS SYNDROME 3 0.0065
69 IMMUNOGLOBULINS INCREASED 3 0.0064
70 DEVICE PROGRAMMING ERROR 2 0.0063
71 COLORECTAL ADENOMA 2 0.0062
72 BODY HEIGHT INCREASED 3 0.0061
73 CATHETER SITE BRUISE 2 0.0060
74 GIARDIASIS 2 0.0059
75 MULTIMORBIDITY 7 0.0058
76 BLOOD IMMUNOGLOBULIN G INCREASED 7 0.0058
77 INFUSION SITE CELLULITIS 3 0.0057
78 GASTROINTESTINAL MICROORGANISM OVERGROWTH 2 0.0057
79 INFUSION SITE INFLAMMATION 4 0.0057
80 DIABETIC GASTROPARESIS 2 0.0054
81 SCROTAL SWELLING 5 0.0053
82 ADMINISTRATION SITE REACTION 2 0.0052
83 HUMIDITY INTOLERANCE 2 0.0050
84 DEATH OF RELATIVE 2 0.0049
85 QUADRIPARESIS 8 0.0048
86 OSTEOPOROTIC FRACTURE 9 0.0047
87 HYPOREFLEXIA 9 0.0047
88 ALLERGIC SINUSITIS 4 0.0047
89 EYELID INFECTION 2 0.0045
90 BODY TEMPERATURE ABNORMAL 8 0.0043
91 EPIDIDYMITIS 5 0.0043
92 MENINGISM 2 0.0043
93 SCROTAL OEDEMA 3 0.0042
94 EVANS SYNDROME 2 0.0041
95 ACUTE SINUSITIS 7 0.0041
96 INSURANCE ISSUE 62 0.0041
97 POST-ACUTE COVID-19 SYNDROME 5 0.0040
98 SKIN STRIAE 6 0.0040
99 BLOOD IMMUNOGLOBULIN M DECREASED 4 0.0040
100 INDURATION 7 0.0039
101 DEVICE ALARM ISSUE 7 0.0039
102 VASCULAR PURPURA 5 0.0036
103 MECHANICAL ILEUS 2 0.0035
104 SERUM FERRITIN DECREASED 6 0.0035
105 FINE MOTOR SKILL DYSFUNCTION 10 0.0035
106 SENSE OF OPPRESSION 4 0.0034
107 SINUSITIS 348 0.0034
108 PRODUCT RECONSTITUTION QUALITY ISSUE 3 0.0034
109 PNEUMOCYSTIS JIROVECII INFECTION 4 0.0033
110 MEDICAL DEVICE SITE INFECTION 2 0.0032
111 CHRONIC SINUSITIS 12 0.0032
112 PROSTATE INFECTION 3 0.0031
113 CELLULITIS STAPHYLOCOCCAL 2 0.0031
114 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 4 0.0030
115 LOWER RESPIRATORY TRACT CONGESTION 5 0.0029
116 POOR VENOUS ACCESS 30 0.0029
117 CRANIAL NERVE DISORDER 2 0.0029
118 PNEUMONIA STREPTOCOCCAL 3 0.0027
119 VULVOVAGINAL SWELLING 5 0.0027
120 BRONCHITIS BACTERIAL 2 0.0026
121 AREFLEXIA 7 0.0026
122 INFUSION SITE INFECTION 6 0.0026
123 FEBRILE INFECTION 3 0.0025
124 DIARRHOEA INFECTIOUS 2 0.0025
125 PRODUCT TEMPERATURE EXCURSION ISSUE 13 0.0025
126 RESPIRATORY SYMPTOM 7 0.0025
127 FEAR OF FALLING 2 0.0025
128 PENILE SWELLING 3 0.0024
129 MENINGITIS 16 0.0024
130 TYMPANIC MEMBRANE PERFORATION 4 0.0024
131 VIRAL UPPER RESPIRATORY TRACT INFECTION 11 0.0023
132 MULTIPLE ALLERGIES 18 0.0023
133 OBSTRUCTION 9 0.0023
134 SIALOADENITIS 3 0.0022
135 NASAL DISCHARGE DISCOLOURATION 3 0.0022
136 MAST CELL ACTIVATION SYNDROME 3 0.0021
137 CATHETER SITE SWELLING 2 0.0021
138 BLADDER SPASM 4 0.0021
139 CEREBRAL PALSY 2 0.0021
140 ANIMAL SCRATCH 2 0.0021
141 DRUG ADMINISTERED IN WRONG DEVICE 2 0.0020
142 DUST ALLERGY 2 0.0020
143 PNEUMONIA PNEUMOCOCCAL 3 0.0020
144 DEEP VEIN THROMBOSIS POSTOPERATIVE 4 0.0020
145 RESPIRATORY TRACT INFECTION 51 0.0020
146 GASTROENTERITIS VIRAL 35 0.0019
147 GASTROINTESTINAL VIRAL INFECTION 2 0.0019
148 EAR INFECTION 51 0.0019
149 BRONCHITIS 140 0.0019
150 ALLERGY TO ANIMAL 2 0.0019
151 SKIN INFECTION 21 0.0019
152 DEVICE OCCLUSION 26 0.0018
153 UPPER RESPIRATORY TRACT INFECTION 85 0.0018
154 PRODUCT DISTRIBUTION ISSUE 17 0.0018
155 LIMB MASS 4 0.0018
156 CLOSTRIDIUM TEST POSITIVE 4 0.0018
157 GASTROINTESTINAL INFECTION 16 0.0018
158 AUTOIMMUNE HAEMOLYTIC ANAEMIA 6 0.0017
159 RESPIRATORY TRACT INFECTION VIRAL 4 0.0017
160 INABILITY TO AFFORD MEDICATION 17 0.0017
161 INJECTION SITE EXTRAVASATION 21 0.0017
162 INFECTED CYST 2 0.0017
163 DERMATITIS CONTACT 19 0.0017
164 VIRAL INFECTION 55 0.0017
165 SINUS DISORDER 32 0.0016
166 INJECTION SITE CELLULITIS 3 0.0016
167 INTRA-ABDOMINAL HAEMATOMA 2 0.0016
168 NASAL OBSTRUCTION 3 0.0016
169 LUPUS VULGARIS 2 0.0016
170 RHINOVIRUS INFECTION 6 0.0015
171 HYPOVITAMINOSIS 2 0.0015
172 BRONCHIECTASIS 10 0.0015
173 SUDDEN HEARING LOSS 3 0.0015
174 DISCHARGE 2 0.0014
175 CHRONIC FATIGUE SYNDROME 2 0.0014
176 HEART RATE ABNORMAL 8 0.0014
177 PRODUCT LEAKAGE 8 0.0014
178 CANDIDA INFECTION 24 0.0014
179 EYE CONTUSION 3 0.0014
180 OXYGEN SATURATION ABNORMAL 4 0.0014
181 CONNECTIVE TISSUE DISORDER 2 0.0014
182 INJECTION SITE HYPOAESTHESIA 2 0.0014
183 NOROVIRUS INFECTION 2 0.0014
184 PERIPHERAL SENSORY NEUROPATHY 8 0.0014
185 MIDDLE EAR EFFUSION 3 0.0014
186 GENITAL PAIN 2 0.0014
187 MYASTHENIA GRAVIS CRISIS 2 0.0013
188 SEASONAL ALLERGY 19 0.0013
189 INFECTIOUS MONONUCLEOSIS 3 0.0013
190 ATYPICAL PNEUMONIA 4 0.0013
191 CHRONIC GASTRITIS 3 0.0013
192 PROSTATITIS 4 0.0013
193 INFUSION RELATED REACTION 87 0.0013
194 FOOD POISONING 7 0.0013
195 INJECTION SITE PARAESTHESIA 2 0.0013
196 HYPERTROPHIC CARDIOMYOPATHY 2 0.0013
197 DISCOURAGEMENT 3 0.0013
198 BACTERIAL VAGINOSIS 2 0.0013
199 ANTIPHOSPHOLIPID SYNDROME 2 0.0012
200 EYE INFECTION 14 0.0012
201 FACET JOINT SYNDROME 4 0.0012
202 EYE OEDEMA 3 0.0012
203 INJECTION SITE ATROPHY 2 0.0012
204 ANAPHYLACTOID REACTION 5 0.0012
205 ABDOMINAL TENDERNESS 6 0.0012
206 SKIN INJURY 4 0.0012
207 PHARYNGITIS STREPTOCOCCAL 13 0.0012
208 PRODUCT AVAILABILITY ISSUE 27 0.0012
209 DEAFNESS BILATERAL 2 0.0012
210 HORDEOLUM 5 0.0012
211 URINE OUTPUT INCREASED 3 0.0011
212 INJECTION SITE DISCOMFORT 12 0.0011
213 ABDOMINAL ABSCESS 5 0.0011
214 INFECTION 163 0.0011
215 PRODUCT SUPPLY ISSUE 8 0.0011
216 SKIN LACERATION 12 0.0011
217 SPONDYLITIS 4 0.0011
218 LOCALISED OEDEMA 5 0.0011
219 BODY TEMPERATURE INCREASED 22 0.0011
220 STREPTOCOCCAL INFECTION 6 0.0011
221 CYSTOID MACULAR OEDEMA 2 0.0011
222 CHRONIC LYMPHOCYTIC LEUKAEMIA 5 0.0011
223 PSEUDOMONAS INFECTION 9 0.0010
224 ILLNESS 108 0.0010
225 GASTRIC INFECTION 4 0.0010
226 HERPES VIRUS INFECTION 6 0.0010
227 CUTANEOUS LUPUS ERYTHEMATOSUS 2 0.0010
228 EAR PAIN 20 0.0010
229 AUTOIMMUNE DISORDER 10 0.0010
230 ADRENOCORTICAL INSUFFICIENCY ACUTE 2 0.0010
231 HEREDITARY ANGIOEDEMA 11 0.0010
232 SKIN ODOUR ABNORMAL 4 0.0010
233 COVID-19 PNEUMONIA 12 0.0010
234 PLEURISY 6 0.0010
235 SINUS HEADACHE 6 0.0010
236 BLADDER DISORDER 10 0.0010
237 NO ADVERSE EVENT 182 0.0010
238 INFLUENZA 111 0.0010
239 LOWER RESPIRATORY TRACT INFECTION 45 0.0010
240 EAR HAEMORRHAGE 2 0.0010
241 MIGRAINE 94 0.0010
242 INJECTION SITE NECROSIS 2 0.0010
243 LYMPHOMA 15 0.0010
244 BLOOD BLISTER 3 0.0010
245 ELECTROENCEPHALOGRAM ABNORMAL 3 0.0009
246 PNEUMONIA VIRAL 3 0.0009
247 ESCHERICHIA URINARY TRACT INFECTION 4 0.0009
248 INJECTION SITE DISCHARGE 5 0.0009
249 PROCEDURAL COMPLICATION 7 0.0009
250 INFLUENZA LIKE ILLNESS 75 0.0009
251 TOOTH INFECTION 12 0.0009
252 SUSPECTED COVID-19 3 0.0009
253 FUNGAL INFECTION 30 0.0009
254 LYME DISEASE 3 0.0009
255 PRODUCT ADMINISTRATION ERROR 18 0.0009
256 FEAR OF DEATH 2 0.0009
257 PRODUCT USE COMPLAINT 14 0.0009
258 DISLOCATION OF VERTEBRA 2 0.0009
259 SWELLING 82 0.0009
260 ABDOMINAL DISTENSION 91 0.0009
261 HYPOPNOEA 3 0.0009
262 TENDERNESS 9 0.0009
263 LOCAL SWELLING 15 0.0009
264 SKIN WARM 5 0.0009
265 FOLLICULITIS 9 0.0009
266 ESCHERICHIA INFECTION 7 0.0009
267 SKIN TIGHTNESS 4 0.0008
268 PRODUCT CONTAMINATION 3 0.0008
269 FEAR OF INJECTION 6 0.0008
270 LYMPHADENITIS 2 0.0008
271 LIQUID PRODUCT PHYSICAL ISSUE 6 0.0008
272 CAROTID ARTERY OCCLUSION 3 0.0008
273 WOUND INFECTION 9 0.0008
274 NASOPHARYNGITIS 151 0.0008
275 BRONCHITIS CHRONIC 2 0.0008
276 BLOOD PRESSURE SYSTOLIC ABNORMAL 2 0.0008
277 CATHETER SITE HAEMORRHAGE 2 0.0008
278 CELLULITIS 40 0.0008
279 PARANASAL SINUS DISCOMFORT 3 0.0008
280 LABYRINTHITIS 2 0.0008
281 KLEBSIELLA INFECTION 4 0.0008
282 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 142 0.0008
283 DISCOMFORT 48 0.0008
284 TOOTH ABSCESS 8 0.0008
285 DIABETIC COMPLICATION 2 0.0008
286 HAEMOLYSIS 6 0.0008
287 MENOPAUSE 2 0.0008
288 BLOOD CHLORIDE DECREASED 2 0.0008
289 CATHETER SITE PAIN 2 0.0008
290 ORAL INFECTION 3 0.0008
291 TONSILLITIS 4 0.0008
292 BEDRIDDEN 10 0.0008
293 SCAR 13 0.0008
294 WALKING AID USER 5 0.0008
295 CORONAVIRUS INFECTION 5 0.0008
296 RESPIRATORY TRACT CONGESTION 12 0.0008
297 RENAL PAIN 8 0.0008
298 RHINITIS 6 0.0007
299 SPINAL FUSION SURGERY 3 0.0007
300 ABDOMINAL RIGIDITY 2 0.0007
301 PERIPHERAL VENOUS DISEASE 3 0.0007
302 URINARY TRACT INFECTION 125 0.0007
303 NONSPECIFIC REACTION 4 0.0007
304 DERMATITIS ALLERGIC 9 0.0007
305 DRUG TOLERANCE DECREASED 2 0.0007
306 IMMUNE THROMBOCYTOPENIC PURPURA 2 0.0007
307 INTERVERTEBRAL DISC DISORDER 3 0.0007
308 INJECTION SITE SCAR 2 0.0007
309 PRODUCT CONTAINER ISSUE 6 0.0007
310 BACTERIAL INFECTION 13 0.0007
311 INCORRECT PRODUCT ADMINISTRATION DURATION 15 0.0007
312 PHOTOPHOBIA 13 0.0007
313 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
314 DEVICE POWER SOURCE ISSUE 2 0.0007
315 ARTHROPOD BITE 5 0.0007
316 ATAXIA 8 0.0007
317 KIDNEY INFECTION 13 0.0007
318 LOCALISED INFECTION 16 0.0007
319 EAR DISORDER 3 0.0007
320 DUODENITIS 2 0.0007
321 ARTHRITIS INFECTIVE 3 0.0006
322 PHARYNGITIS 8 0.0006
323 APHTHOUS ULCER 5 0.0006
324 FLANK PAIN 6 0.0006
325 VAGINAL INFECTION 3 0.0006
326 HEADACHE 395 0.0006
327 BLADDER PAIN 2 0.0006
328 CYSTITIS 20 0.0006
329 PARAESTHESIA ORAL 9 0.0006
330 COVID-19 109 0.0006
331 RASH VESICULAR 3 0.0006
332 NEEDLE ISSUE 18 0.0006
333 NEURALGIA 15 0.0006
334 HERPES SIMPLEX 4 0.0006
335 HORMONE LEVEL ABNORMAL 3 0.0006
336 LYMPHOCYTE COUNT INCREASED 2 0.0006
337 PRODUCT PREPARATION ISSUE 4 0.0006
338 HYPOGAMMAGLOBULINAEMIA 4 0.0006
339 PYREXIA 210 0.0006
340 STAPHYLOCOCCAL INFECTION 20 0.0006
341 CHILLS 71 0.0006
342 GASTROINTESTINAL SOUNDS ABNORMAL 3 0.0006
343 IMMUNODEFICIENCY 9 0.0006
344 MENSTRUAL DISORDER 5 0.0006
345 SKIN MASS 4 0.0006
346 SPINAL PAIN 7 0.0006
347 BREAST MASS 4 0.0006
348 HEPATIC CYST 2 0.0006
349 PETIT MAL EPILEPSY 3 0.0006
350 PNEUMONIA 190 0.0006
351 FACIAL PARALYSIS 5 0.0006
352 HELICOBACTER INFECTION 6 0.0006
353 FOOT FRACTURE 11 0.0006
354 LYMPHOEDEMA 4 0.0006
355 SKIN NECROSIS 3 0.0006
356 DEPRESSION SUICIDAL 2 0.0006
357 PETECHIAE 6 0.0006
358 HERPES ZOSTER 33 0.0006
359 WEIGHT FLUCTUATION 6 0.0006
360 CAROTID ARTERY STENOSIS 2 0.0006
361 URINE OUTPUT DECREASED 5 0.0006
362 THERMAL BURN 4 0.0006
363 HAEMOLYTIC ANAEMIA 5 0.0006
364 INJECTION SITE IRRITATION 7 0.0005
365 PREGNANCY 11 0.0005
366 BRAIN NEOPLASM 5 0.0005
367 ANAPHYLACTIC REACTION 30 0.0005
368 RASH GENERALISED 14 0.0005
369 DUODENAL ULCER PERFORATION 4 0.0005
370 HYPERACUSIS 2 0.0005
371 BONE DENSITY ABNORMAL 2 0.0005
372 OROPHARYNGEAL PAIN 49 0.0005
373 CHEMOTHERAPY 2 0.0005
374 THROAT TIGHTNESS 14 0.0005
375 CONCUSSION 4 0.0005
376 LUNG INFECTION 8 0.0005
377 IMPAIRED GASTRIC EMPTYING 7 0.0005
378 THERAPY PARTIAL RESPONDER 8 0.0005
379 POOR QUALITY SLEEP 11 0.0005
380 COLD SWEAT 9 0.0005
381 LUNG DISORDER 25 0.0005
382 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
383 LIGAMENT SPRAIN 5 0.0005
384 TYPE 1 DIABETES MELLITUS 3 0.0005
385 FRUSTRATION TOLERANCE DECREASED 4 0.0005
386 MALAISE 216 0.0005
387 POST PROCEDURAL INFECTION 4 0.0005
388 VULVOVAGINAL BURNING SENSATION 3 0.0005
389 PRODUCT STORAGE ERROR 43 0.0005
390 BLOOD PRESSURE INCREASED 75 0.0005
391 CONTUSION 47 0.0005
392 EMBOLISM 4 0.0005
393 LIMB INJURY 13 0.0005
394 PALLOR 13 0.0005
395 URTICARIA 80 0.0005
396 INJECTION SITE SWELLING 36 0.0005
397 ABSCESS LIMB 2 0.0005
398 HEPATIC PAIN 2 0.0005
399 RESPIRATORY DISORDER 14 0.0005
400 ROTATOR CUFF SYNDROME 6 0.0005
401 MUSCULOSKELETAL DISCOMFORT 8 0.0005
402 CARDIAC FLUTTER 3 0.0005
403 MUSCLE STRAIN 4 0.0005
404 ORAL HERPES 9 0.0005
405 PRODUCTIVE COUGH 22 0.0005
406 MONOPLEGIA 2 0.0005
407 PRODUCT PRESCRIBING ISSUE 10 0.0005
408 NAIL DISORDER 4 0.0005
409 ASPERGILLUS INFECTION 3 0.0005
410 BLOOD CALCIUM INCREASED 4 0.0005
411 HYPERSOMNIA 13 0.0005
412 LIGAMENT RUPTURE 2 0.0005
413 ADVERSE REACTION 6 0.0005
414 ANKLE FRACTURE 7 0.0005
415 LYMPHADENOPATHY 16 0.0005
416 BRAIN FOG 7 0.0004
417 IRON DEFICIENCY 2 0.0004
418 ERYTHEMA 91 0.0004
419 ASTHMA 50 0.0004
420 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 23 0.0004
421 OPTIC NEURITIS 4 0.0004
422 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
423 HAEMOGLOBIN INCREASED 2 0.0004
424 ABDOMINAL HERNIA 2 0.0004
425 SKIN LESION 12 0.0004
426 IMMUNE THROMBOCYTOPENIA 2 0.0004
427 LUMBAR VERTEBRAL FRACTURE 2 0.0004
428 ONYCHOCLASIS 3 0.0004
429 PNEUMONIA BACTERIAL 4 0.0004
430 RESPIRATION ABNORMAL 3 0.0004
431 PERIPHERAL SWELLING 67 0.0004
432 ENCEPHALITIS 3 0.0004
433 NERVE COMPRESSION 4 0.0004
434 DIVERTICULITIS 12 0.0004
435 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
436 NECK PAIN 24 0.0004
437 MOUTH ULCERATION 9 0.0004
438 BLOOD TEST ABNORMAL 6 0.0004
439 SPLENOMEGALY 5 0.0004
440 SYSTEMIC LUPUS ERYTHEMATOSUS 15 0.0004
441 INCORRECT DOSE ADMINISTERED 96 0.0004
442 ENDOMETRIOSIS 2 0.0004
443 WHITE BLOOD CELL COUNT INCREASED 16 0.0004
444 LOWER LIMB FRACTURE 8 0.0004
445 HERNIA 8 0.0004
446 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
447 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
448 BURSITIS 5 0.0004
449 FIBROMYALGIA 10 0.0004
450 INCORRECT DOSAGE ADMINISTERED 2 0.0004
451 DECREASED IMMUNE RESPONSIVENESS 4 0.0004
452 NASAL POLYPS 2 0.0004
453 INJECTION SITE PRURITUS 27 0.0004
454 CYST 5 0.0004
455 GASTROINTESTINAL DISORDER 36 0.0004
456 APPLICATION SITE SWELLING 2 0.0004
457 PRODUCT DOSE OMISSION ISSUE 118 0.0004
458 FATIGUE 312 0.0004
459 RASH MACULAR 14 0.0004
460 INJECTION SITE DISCOLOURATION 5 0.0004
461 SECRETION DISCHARGE 5 0.0004
462 DRUG LEVEL DECREASED 4 0.0004
463 INJURY ASSOCIATED WITH DEVICE 8 0.0004
464 LIP SWELLING 13 0.0004
465 RIB FRACTURE 8 0.0004
466 CACHEXIA 2 0.0004
467 FOOD ALLERGY 3 0.0004
468 EXPOSURE DURING PREGNANCY 24 0.0004
469 BURNING SENSATION 27 0.0004
470 MALABSORPTION 2 0.0004
471 POOR QUALITY PRODUCT ADMINISTERED 4 0.0004
472 IMMUNE SYSTEM DISORDER 5 0.0004
473 INJECTION SITE ERYTHEMA 47 0.0004
474 NASAL DISCOMFORT 3 0.0004
475 PNEUMOTHORAX 6 0.0004
476 CONJUNCTIVITIS 7 0.0004
477 ABSCESS 6 0.0004
478 MALIGNANT MELANOMA 5 0.0004
479 COUGH 104 0.0004
480 GINGIVITIS 2 0.0004
481 PULMONARY THROMBOSIS 4 0.0004
482 SLEEP APNOEA SYNDROME 7 0.0004
483 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
484 POST PROCEDURAL COMPLICATION 7 0.0004
485 PERIPHERAL COLDNESS 5 0.0004
486 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 3 0.0004
487 DEAFNESS UNILATERAL 2 0.0004
488 SPINAL COMPRESSION FRACTURE 3 0.0004
489 CHOKING SENSATION 2 0.0004
490 RED BLOOD CELL SEDIMENTATION RATE INCREASED 4 0.0004
491 SKIN DISORDER 12 0.0004
492 NECROSIS 2 0.0004
493 ANGIOPATHY 2 0.0004
494 LIMB DISCOMFORT 11 0.0004
495 BLINDNESS UNILATERAL 5 0.0004
496 PAIN 216 0.0004
497 THROMBOSIS 28 0.0003
498 SKIN SWELLING 3 0.0003
499 PRURITUS 132 0.0003
500 RENAL DISORDER 16 0.0003
501 VASCULITIS 4 0.0003
502 JOINT STIFFNESS 9 0.0003
503 FEELING ABNORMAL 82 0.0003
504 DRUG INTOLERANCE 33 0.0003
505 GRIP STRENGTH DECREASED 3 0.0003
506 INJECTION SITE WARMTH 7 0.0003
507 ENERGY INCREASED 2 0.0003
508 DRUG ERUPTION 6 0.0003
509 WHEEZING 20 0.0003
510 FACIAL PAIN 3 0.0003
511 PRODUCT PRESCRIBING ERROR 8 0.0003
512 FLUID RETENTION 17 0.0003
513 POLYNEUROPATHY 4 0.0003
514 BLOOD PRESSURE FLUCTUATION 8 0.0003
515 HEPATITIS B 2 0.0003
516 HYPOAESTHESIA ORAL 5 0.0003
517 BACK PAIN 77 0.0003
518 INJECTION SITE VESICLES 2 0.0003
519 PRODUCT USE ISSUE 62 0.0003
520 INGUINAL HERNIA 2 0.0003
521 EXOSTOSIS 3 0.0003
522 INJECTION SITE MASS 12 0.0003
523 THYROID DISORDER 5 0.0003
524 DEEP VEIN THROMBOSIS 21 0.0003
525 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
526 BLEPHAROSPASM 2 0.0003
527 SPINAL DISORDER 3 0.0003
528 SPUTUM DISCOLOURED 3 0.0003
529 PRODUCT PACKAGING ISSUE 3 0.0003
530 WEIGHT DECREASED 88 0.0003
531 HYPERSENSITIVITY 58 0.0003
532 C-REACTIVE PROTEIN ABNORMAL 2 0.0003
533 OCCUPATIONAL EXPOSURE TO PRODUCT 2 0.0003
534 HAEMOGLOBIN ABNORMAL 2 0.0003
535 NIGHT SWEATS 10 0.0003
536 PRESCRIBED OVERDOSE 6 0.0003
537 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 22 0.0003
538 HIATUS HERNIA 4 0.0003
539 BREAST CANCER STAGE III 2 0.0003
540 HAEMATOMA 8 0.0003
541 INJECTION SITE INDURATION 4 0.0003
542 BACK DISORDER 5 0.0003
543 THERAPY CHANGE 3 0.0003
544 ORAL CANDIDIASIS 4 0.0003
545 DISABILITY 6 0.0003
546 CHEST DISCOMFORT 31 0.0003
547 BLOOD PRESSURE DECREASED 20 0.0003
548 DYSURIA 11 0.0003
549 PERICARDITIS 5 0.0003
550 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
551 UVEITIS 4 0.0003
552 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
553 EPILEPSY 9 0.0003
554 ARTHRITIS 23 0.0003
555 OSTEOPOROSIS 12 0.0003
556 ECCHYMOSIS 2 0.0003
557 TEMPERATURE INTOLERANCE 3 0.0003
558 JOINT EFFUSION 2 0.0003
559 THROAT IRRITATION 13 0.0003
560 DERMATITIS 6 0.0003
561 MASS 4 0.0003
562 WOUND 8 0.0003
563 CARPAL TUNNEL SYNDROME 4 0.0003
564 INJECTION SITE URTICARIA 7 0.0003
565 HEAD DISCOMFORT 5 0.0003
566 HAND FRACTURE 2 0.0003
567 EATING DISORDER 6 0.0003
568 NAUSEA 221 0.0003
569 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
570 GOUT 5 0.0003
571 RHINORRHOEA 18 0.0003
572 PRURITUS GENERALISED 6 0.0003
573 FEELING HOT 17 0.0003
574 RASH PRURITIC 15 0.0003
575 TOOTHACHE 5 0.0003
576 PAIN IN EXTREMITY 81 0.0003
577 INTENTIONAL PRODUCT USE ISSUE 24 0.0003
578 HYPOAESTHESIA 41 0.0003
579 NASAL CONGESTION 16 0.0003
580 TOOTH FRACTURE 3 0.0003
581 RASH ERYTHEMATOUS 13 0.0003
582 INFLAMMATION 14 0.0003
583 DENTAL CARIES 3 0.0003
584 BLOOD GLUCOSE ABNORMAL 5 0.0003
585 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
586 GAIT INABILITY 9 0.0003
587 PULMONARY MASS 4 0.0003
588 INTESTINAL PERFORATION 3 0.0003
589 KETOACIDOSIS 2 0.0003
590 ADVERSE DRUG REACTION 24 0.0003
591 BLOOD SODIUM DECREASED 5 0.0003
592 BLOOD URINE PRESENT 5 0.0003
593 MICTURITION URGENCY 3 0.0003
594 NEPHROLITHIASIS 12 0.0003
595 NEOPLASM 3 0.0003
596 PULMONARY FIBROSIS 5 0.0003
597 MUSCULOSKELETAL CHEST PAIN 4 0.0003
598 BASAL CELL CARCINOMA 4 0.0003
599 PLASMA CELL MYELOMA 10 0.0003
600 SWOLLEN TONGUE 8 0.0003
601 FLUSHING 26 0.0003
602 WEIGHT INCREASED 57 0.0003
603 CYANOSIS 4 0.0003
604 BLOOD IRON DECREASED 3 0.0003
605 HEAD INJURY 8 0.0003
606 BACTERAEMIA 3 0.0003
607 PROCEDURAL PAIN 7 0.0003
608 BLOOD PRESSURE ABNORMAL 5 0.0003
609 MUSCULOSKELETAL STIFFNESS 22 0.0003
610 SCIATICA 4 0.0003
611 BLOOD DISORDER 2 0.0002
612 ABDOMINAL PAIN 58 0.0002
613 BLISTER 14 0.0002
614 HIP FRACTURE 8 0.0002
615 CHEST PAIN 46 0.0002
616 ASTHENIA 93 0.0002
617 ADRENAL INSUFFICIENCY 3 0.0002
618 PAIN IN JAW 7 0.0002
619 MUSCLE TIGHTNESS 4 0.0002
620 PRESYNCOPE 6 0.0002
621 UNDERDOSE 18 0.0002
622 TASTE DISORDER 5 0.0002
623 DECUBITUS ULCER 2 0.0002
624 SMALL INTESTINAL OBSTRUCTION 3 0.0002
625 SPINAL OPERATION 3 0.0002
626 PRODUCT PREPARATION ERROR 5 0.0002
627 LETHARGY 14 0.0002
628 ARTHRALGIA 101 0.0002
629 DYSPHAGIA 23 0.0002
630 PHOTOSENSITIVITY REACTION 4 0.0002
631 CYTOMEGALOVIRUS INFECTION 4 0.0002
632 COAGULOPATHY 4 0.0002
633 OEDEMA 13 0.0002
634 TINNITUS 11 0.0002
635 ATRIAL SEPTAL DEFECT 2 0.0002
636 MUSCULAR WEAKNESS 27 0.0002
637 LABORATORY TEST ABNORMAL 7 0.0002
638 MUSCLE ATROPHY 3 0.0002
639 CIRCULATORY COLLAPSE 4 0.0002
640 JOINT INJURY 5 0.0002
641 IRRITABLE BOWEL SYNDROME 5 0.0002
642 SEPSIS 26 0.0002
643 LIVER FUNCTION TEST INCREASED 5 0.0002
644 BLOOD MAGNESIUM DECREASED 2 0.0002
645 CARDIAC MURMUR 2 0.0002
646 DEVICE LEAKAGE 10 0.0002
647 MUSCLE SPASMS 42 0.0002
648 DEVICE USE ISSUE 4 0.0002
649 SARS-COV-2 TEST POSITIVE 3 0.0002
650 PANCREATITIS 12 0.0002
651 IMMUNOSUPPRESSION 2 0.0002
652 HYPERHIDROSIS 29 0.0002
653 RASH 98 0.0002
654 MYOSITIS 2 0.0002
655 ANAL INCONTINENCE 2 0.0002
656 HEART RATE INCREASED 22 0.0002
657 CHROMATURIA 5 0.0002
658 RESTLESS LEGS SYNDROME 4 0.0002
659 HIDRADENITIS 2 0.0002
660 CATARACT 13 0.0002
661 SKIN DISCOLOURATION 10 0.0002
662 ABNORMAL DREAMS 6 0.0002
663 IRON DEFICIENCY ANAEMIA 2 0.0002
664 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
665 GENERAL PHYSICAL HEALTH DETERIORATION 25 0.0002
666 ORAL DISCOMFORT 3 0.0002
667 SWELLING FACE 14 0.0002
668 APHONIA 3 0.0002
669 VOMITING 101 0.0002
670 HEPATIC STEATOSIS 4 0.0002
671 ABDOMINAL DISCOMFORT 36 0.0002
672 ERYTHEMA MULTIFORME 2 0.0002
673 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 10 0.0002
674 OXYGEN SATURATION DECREASED 12 0.0002
675 FALL 71 0.0002
676 INJECTION SITE BRUISING 17 0.0002
677 SKIN REACTION 3 0.0002
678 HEPATIC CIRRHOSIS 4 0.0002
679 ARTERIOSCLEROSIS 2 0.0002
680 INTESTINAL OBSTRUCTION 8 0.0002
681 LEUKAEMIA 2 0.0002
682 MYALGIA 36 0.0002
683 COLITIS 8 0.0002
684 GASTRIC ULCER 4 0.0002
685 EYE INFLAMMATION 2 0.0002
686 IMPAIRED QUALITY OF LIFE 3 0.0002
687 ACCIDENTAL UNDERDOSE 3 0.0002
688 ATELECTASIS 2 0.0002
689 GASTROENTERITIS 3 0.0002
690 HEPATIC ENZYME INCREASED 14 0.0002
691 GAIT DISTURBANCE 39 0.0002
692 HEPATOMEGALY 2 0.0002
693 KNEE OPERATION 2 0.0002
694 BODY TEMPERATURE DECREASED 2 0.0002
695 SKIN HAEMORRHAGE 3 0.0002
696 UPPER LIMB FRACTURE 4 0.0002
697 PRESCRIBED UNDERDOSE 4 0.0002
698 PNEUMONIA ASPIRATION 5 0.0002
699 LEUKOPENIA 10 0.0002
700 ABORTION SPONTANEOUS 8 0.0002
701 SPINAL FRACTURE 4 0.0002
702 BLOOD POTASSIUM DECREASED 6 0.0002
703 HEART RATE DECREASED 7 0.0002
704 INJECTION SITE PAIN 61 0.0002
705 FULL BLOOD COUNT DECREASED 4 0.0002
706 BLOOD COUNT ABNORMAL 3 0.0002
707 PARAESTHESIA 31 0.0002
708 DRY THROAT 2 0.0002
709 SKIN IRRITATION 9 0.0002
710 HYPOPHAGIA 5 0.0002
711 PHARYNGEAL OEDEMA 3 0.0002
712 EYE PAIN 11 0.0002
713 BLOOD CHOLESTEROL INCREASED 9 0.0002
714 EYE DISCHARGE 2 0.0002
715 SEIZURE 22 0.0002
716 RENAL IMPAIRMENT 16 0.0002
717 ABDOMINAL PAIN UPPER 39 0.0002
718 INCONTINENCE 2 0.0002
719 JOINT DISLOCATION 2 0.0002
720 INJECTION SITE REACTION 13 0.0002
721 ULCER 3 0.0002
722 BODY HEIGHT DECREASED 2 0.0002
723 BREAST CANCER METASTATIC 2 0.0002
724 DRUG EFFECT DECREASED 10 0.0002
725 UNEVALUABLE EVENT 14 0.0002
726 BLOOD CREATININE INCREASED 12 0.0002
727 DYSPNOEA 104 0.0002
728 PRODUCT DISPENSING ERROR 4 0.0002
729 INTERVERTEBRAL DISC PROTRUSION 4 0.0002
730 ASPIRATION 2 0.0002
731 THERAPY INTERRUPTED 13 0.0002
732 CARDIAC DISORDER 17 0.0002
733 STOMATITIS 11 0.0002
734 VERTIGO 11 0.0002
735 SYNCOPE 18 0.0002
736 TOOTH DISORDER 4 0.0002
737 URINARY RETENTION 6 0.0002
738 HYPERTENSIVE CRISIS 2 0.0002
739 FEELING COLD 5 0.0002
740 LOSS OF CONSCIOUSNESS 23 0.0002
741 HAEMOPTYSIS 5 0.0002
742 PULMONARY OEDEMA 8 0.0002
743 ORAL PAIN 4 0.0002
744 RASH PAPULAR 4 0.0002
745 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
746 SKIN EXFOLIATION 15 0.0002
747 ATRIAL FIBRILLATION 17 0.0002
748 EPISTAXIS 13 0.0002
749 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 35 0.0002
750 DYSKINESIA 7 0.0002
751 ECZEMA 9 0.0002
752 SYRINGE ISSUE 3 0.0002
753 DYSSTASIA 5 0.0002
754 DIZZINESS 85 0.0002
755 URINARY INCONTINENCE 5 0.0002
756 PULMONARY EMBOLISM 16 0.0002
757 NEUROPATHY PERIPHERAL 16 0.0002
758 GALLBLADDER DISORDER 3 0.0002
759 CHOLECYSTITIS 2 0.0002
760 DEVICE ISSUE 15 0.0002
761 MUSCLE RIGIDITY 2 0.0002
762 OSTEOMYELITIS 3 0.0002
763 OSTEOARTHRITIS 7 0.0002
764 DEATH 141 0.0002
765 ADVERSE EVENT 15 0.0002
766 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
767 GASTROOESOPHAGEAL REFLUX DISEASE 13 0.0002
768 PRODUCT USE IN UNAPPROVED INDICATION 40 0.0002
769 NERVOUS SYSTEM DISORDER 5 0.0002
770 DYSARTHRIA 6 0.0002
771 BRAIN OEDEMA 2 0.0002
772 JOINT SWELLING 19 0.0002
773 OEDEMA PERIPHERAL 19 0.0002
774 GLAUCOMA 3 0.0002
775 CONDITION AGGRAVATED 47 0.0002
776 HAEMORRHOIDS 3 0.0002
777 CHOKING 3 0.0002
778 SKIN FISSURES 3 0.0002
779 NODULE 2 0.0002
780 HAEMORRHAGE 16 0.0002
781 MUCOSAL INFLAMMATION 4 0.0002
782 IMPAIRED HEALING 5 0.0002
783 GASTRITIS 4 0.0002
784 DEPRESSED MOOD 8 0.0002
785 HAEMATOCRIT DECREASED 3 0.0002
786 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
787 EYE HAEMORRHAGE 2 0.0001
788 NEOPLASM MALIGNANT 10 0.0001
789 HAIR TEXTURE ABNORMAL 2 0.0001
790 PAIN OF SKIN 4 0.0001
791 TYPE 2 DIABETES MELLITUS 5 0.0001
792 ILL-DEFINED DISORDER 9 0.0001
793 BLOOD GLUCOSE DECREASED 7 0.0001
794 PALPITATIONS 17 0.0001
795 TREMOR 24 0.0001
796 HUNGER 2 0.0001
797 ROAD TRAFFIC ACCIDENT 6 0.0001
798 HOSPITALISATION 22 0.0001
799 DEVICE MALFUNCTION 10 0.0001
800 INJURY 10 0.0001
801 ANXIETY 40 0.0001
802 IMPAIRED WORK ABILITY 3 0.0001
803 RED BLOOD CELL COUNT DECREASED 4 0.0001
804 SKIN CANCER 3 0.0001
805 MYELODYSPLASTIC SYNDROME 2 0.0001
806 MENTAL DISORDER 6 0.0001
807 HYPOKINESIA 2 0.0001
808 CRYING 5 0.0001
809 DYSPHONIA 8 0.0001
810 BONE PAIN 8 0.0001
811 HAEMOGLOBIN DECREASED 14 0.0001
812 ASCITES 4 0.0001
813 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
814 DEHYDRATION 18 0.0001
815 SNEEZING 3 0.0001
816 DIARRHOEA 86 0.0001
817 CONSTIPATION 29 0.0001
818 HEART RATE IRREGULAR 3 0.0001
819 HYPERTENSION 28 0.0001
820 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
821 DEVICE FAILURE 2 0.0001
822 PLATELET COUNT DECREASED 14 0.0001
823 ANAEMIA 25 0.0001
824 INJECTION SITE RASH 4 0.0001
825 MUSCLE TWITCHING 3 0.0001
826 SOMNOLENCE 26 0.0001
827 BALANCE DISORDER 11 0.0001
828 PRODUCT QUALITY ISSUE 17 0.0001
829 TACHYCARDIA 11 0.0001
830 HYPOGLYCAEMIA 6 0.0001
831 PSORIATIC ARTHROPATHY 5 0.0001
832 BLOOD POTASSIUM INCREASED 2 0.0001
833 PRODUCT DOSE OMISSION 8 0.0001
834 MANIA 2 0.0001
835 VISUAL IMPAIRMENT 15 0.0001
836 DECREASED APPETITE 28 0.0001
837 POLLAKIURIA 5 0.0001
838 DEPRESSION 27 0.0001
839 CARDIOVASCULAR DISORDER 3 0.0001
840 HAEMATURIA 4 0.0001
841 GASTRIC DISORDER 4 0.0001
842 THROMBOCYTOPENIA 13 0.0001
843 DEVICE DEFECTIVE 2 0.0001
844 PLEURAL EFFUSION 7 0.0001
845 NERVOUSNESS 6 0.0001
846 MYOCARDIAL INFARCTION 20 0.0001
847 RHEUMATOID ARTHRITIS 13 0.0001
848 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
849 METASTASES TO LIVER 2 0.0001
850 ANGIOEDEMA 5 0.0001
851 LIVER DISORDER 5 0.0001
852 INJECTION SITE HAEMORRHAGE 9 0.0001
853 ALOPECIA 22 0.0001
854 SKIN BURNING SENSATION 8 0.0001
855 WHITE BLOOD CELL COUNT DECREASED 12 0.0001
856 PNEUMONITIS 3 0.0001
857 BONE DISORDER 2 0.0001
858 RESPIRATORY FAILURE 8 0.0001
859 TREATMENT NONCOMPLIANCE 6 0.0001
860 DEVICE DELIVERY SYSTEM ISSUE 3 0.0001
861 ARTHROPATHY 6 0.0001
862 EYE SWELLING 4 0.0001
863 DEMENTIA 3 0.0001
864 MIDDLE INSOMNIA 2 0.0001
865 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
866 FRACTURE 2 0.0001
867 FEBRILE NEUTROPENIA 7 0.0001
868 CHRONIC KIDNEY DISEASE 8 0.0001
869 COMA 5 0.0001
870 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
871 OFF LABEL USE 91 0.0001
872 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
873 VISION BLURRED 14 0.0001
874 ACUTE MYOCARDIAL INFARCTION 3 0.0001
875 CEREBROVASCULAR ACCIDENT 17 0.0001
876 LACRIMATION INCREASED 3 0.0001
877 DRY MOUTH 8 0.0001
878 NEUTROPHIL COUNT DECREASED 4 0.0001
879 INSOMNIA 26 0.0001
880 THERAPY CESSATION 5 0.0001
881 FEMUR FRACTURE 3 0.0001
882 NEUTROPENIA 13 0.0001
883 KNEE ARTHROPLASTY 2 0.0001
884 HYPOTENSION 19 0.0001
885 MOVEMENT DISORDER 3 0.0001
886 HYPOACUSIS 4 0.0001
887 DISTURBANCE IN ATTENTION 5 0.0001
888 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
889 SEPTIC SHOCK 4 0.0001
890 OSTEONECROSIS 3 0.0001
891 EYE DISORDER 3 0.0001
892 DEVICE DIFFICULT TO USE 6 0.0001
893 EYE PRURITUS 3 0.0001
894 CARDIAC FAILURE CONGESTIVE 7 0.0001
895 NIGHTMARE 3 0.0001
896 DELIRIUM 3 0.0001
897 BREAST CANCER 8 0.0001
898 COGNITIVE DISORDER 4 0.0001
899 CEREBRAL HAEMORRHAGE 3 0.0001
900 MENTAL IMPAIRMENT 2 0.0001
901 C-REACTIVE PROTEIN INCREASED 3 0.0001
902 PANIC ATTACK 3 0.0001
903 LIVER INJURY 2 0.0001
904 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
905 ABASIA 2 0.0001
906 AGEUSIA 2 0.0001
907 DYSPNOEA EXERTIONAL 3 0.0001
908 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
909 ABDOMINAL PAIN LOWER 2 0.0001
910 DRUG DOSE OMISSION 13 0.0001
911 ANAPHYLACTIC SHOCK 2 0.0001
912 DEAFNESS 2 0.0001
913 DEPRESSED LEVEL OF CONSCIOUSNESS 3 0.0001
914 BRADYCARDIA 4 0.0001
915 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
916 MENSTRUATION IRREGULAR 2 0.0001
917 BLOOD BILIRUBIN INCREASED 2 0.0001
918 MEMORY IMPAIRMENT 10 0.0001
919 MEDICATION ERROR 4 0.0001
920 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
921 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
922 FLATULENCE 4 0.0001
923 RECTAL HAEMORRHAGE 3 0.0001
924 ANGINA PECTORIS 2 0.0001
925 EYE IRRITATION 4 0.0001
926 DEVICE DISLOCATION 3 0.0001
927 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
928 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
929 COLITIS ULCERATIVE 3 0.0001
930 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
931 HOT FLUSH 5 0.0001
932 APHASIA 2 0.0001
933 ACNE 5 0.0001
934 DRUG ADMINISTRATION ERROR 2 0.0001
935 HYPOKALAEMIA 3 0.0001
936 EMOTIONAL DISORDER 2 0.0001
937 ARRHYTHMIA 3 0.0001
938 OCULAR HYPERAEMIA 3 0.0001
939 RENAL CANCER 3 0.0001
940 HYPOTHYROIDISM 2 0.0001
941 CARDIAC FAILURE 5 0.0001
942 CARDIAC ARREST 5 0.0001
943 DRY EYE 3 0.0001
944 ANGER 2 0.0001
945 ACCIDENTAL EXPOSURE TO PRODUCT 6 0.0001
946 MUSCULOSKELETAL PAIN 3 0.0001
947 HYPOXIA 2 0.0001
948 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
949 HYPERGLYCAEMIA 2 0.0001
950 DRUG INEFFECTIVE 72 0.0001
951 PANCYTOPENIA 3 0.0001
952 HEPATIC FUNCTION ABNORMAL 2 0.0001
953 BLOOD GLUCOSE INCREASED 10 0.0001
954 DIABETES MELLITUS 4 0.0001
955 SURGERY 3 0.0001
956 DISORIENTATION 2 0.0001
957 IRRITABILITY 3 0.0000
958 CONFUSIONAL STATE 8 0.0000
959 SUICIDE ATTEMPT 3 0.0000
960 EXTRA DOSE ADMINISTERED 2 0.0000
961 DEVICE BREAKAGE 2 0.0000
962 FOETAL EXPOSURE DURING PREGNANCY 4 0.0000
963 BLINDNESS 2 0.0000
964 LUNG NEOPLASM MALIGNANT 2 0.0000
965 CARDIO-RESPIRATORY ARREST 2 0.0000
966 RENAL FAILURE 6 0.0000
967 DRY SKIN 6 0.0000
968 SLEEP DISORDER 3 0.0000
969 DISEASE RECURRENCE 2 0.0000
970 AGITATION 3 0.0000
971 DYSPEPSIA 4 0.0000
972 AGGRESSION 2 0.0000
973 HALLUCINATION 3 0.0000
974 PSORIASIS 5 0.0000
975 DERMATITIS ATOPIC 2 0.0000
976 DRUG INTERACTION 6 0.0000
977 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
978 DISEASE PROGRESSION 4 0.0000
979 ACUTE KIDNEY INJURY 5 0.0000
980 AMNESIA 2 0.0000
981 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
982 MOBILITY DECREASED 2 0.0000
983 DYSGEUSIA 2 0.0000
984 DRUG DOSE OMISSION BY DEVICE 2 0.0000
985 EMOTIONAL DISTRESS 2 0.0000